Inappropriate Antibiotic Use in a Tertiary Care Center in Thailand: An Incidence Study and Review of Experience in Thailand
The incidence and patterns of and factors associated with inappropriate antibiotic use were studied in a tertiary care center in Thailand. The incidence of inappropriate antibiotic use was 25%. Admission to the surgical department (adjusted odds ratio, 2.0;
) and to the obstetrics and gynecology department (adjusted odds ratio, 2.0;
) were associated with inappropriate antibiotic use, whereas consultation with an infectious diseases specialist was protective against inappropriate antibiotic use (adjusted odds ratio, 0.15;
).
Received January 26, 2005; accepted March 28, 2005; electronically published March 9, 2006.
Inappropriate antibiotic use (IAU) leads to a variety of adverse outcomes, including unnecessary exposure to medications, persistent or progressive infections, superinfection, and increased costs.1 The evolution of antibiotic resistance is also clearly related to overuse of antibiotics, especially in developing countries, where antibiotics can be purchased without a prescription.2 Antibiotic resistance among gram‐positive and gram‐negative organisms has increased significantly in Thailand.3‐5 Despite these concerns, there is a paucity of data regarding IAU in Thailand. We performed 2 period‐incidence surveys to assess the incidence and patterns of and factors associated with IAU at a tertiary care hospital. We also reviewed the relevant literature regarding antibiotic use in tertiary care hospitals in Thailand.
Methods
Thammasart University Hospital (Pratumthani, Thailand) is a level III, 350‐bed, tertiary care university hospital in central Thailand. It has a 150‐mile radius referral base, with 17 patient care service units and departments. Each unit is staffed with 1 attending physician and residents, interns, and medical students. Antibiotics are prescribed directly by attending physicians, residents, and interns or by medical students who are under the supervision of an attending physician. There are 2 infectious diseases specialists (one adult and one pediatric) who evaluate patients with infectious diseases on a consultation basis. At the time of this study, there were no existing policies for antibiotic use at this hospital.
Two separate period‐incidence surveys were performed on May 15, 2004, and June 15, 2004, to assess the incidence and patterns of and factors associated with IAU. All patients hospitalized in 17 units were surveyed. Inpatients receiving antibiotics were included in the study and were monitored until discharge. Each admitted patient for whom antibiotics were prescribed was visited 3 times: (1) at the time of the survey, to document the empirical use of antibiotics; (2) 72 hours later, when microbiologic laboratory results were available; and (3) on the day of discharge, when the final diagnosis was available. Data collected included patients’ demographic characteristics, underlying diseases, severity of illness (acute physiology and chronic health evaluation II score), hospital unit, prescribing physician, antibiotic type, indication for antibiotic prescription, surgical operation, request for infectious diseases consultation, appropriateness of antibiotic use, and category of IAU. From the patient’s chart, it was determined whether therapy was intended for empirical treatment of infection, surgical prophylaxis, or treatment of a documented infection. All data were collected by one investigator. Prescribing physicians were unaware of the purpose of this study at the time of chart review.
We used existing published guidelines for appropriate antibiotic use. Specific use categories were modeled after those of Kunin et al.6 and were modified to fit local practices by an expert panel consisting of 2 infectious diseases physicians who were not directly involved in the clinical care of the study patients. Modifications were also made to accommodate susceptibility patterns and management of some diseases peculiar to Southeast Asia, such as melioidosis. For patients who received surgical prophylaxis, assessment of appropriateness also included the specific type of antibiotic and the dose and duration of prophylaxis administered before and after surgery.7 The measurements were performed either once or twice. For the majority of patients, for whom the empirical and final diagnoses were similar, the measurement was undertaken only once. Measurements were performed twice for patients whose diagnosis at admission was later modified and for whom treatment was revised in response to culture results. Measurements were performed by one investigator, who was blinded to the prescriber and patient identification data.
Categorical variables were compared using the χ2 or Fisher exact test, as appropriate, and continuous variables were compared using the Mann‐Whitney U test. All tests were 2‐tailed, with
considered to be statistically significant.
Results
During the study period, 502 patients were admitted to the hospital. Antibiotics were prescribed for 319 patients (64%). Of those 319 patients, 126 (39%) received antibiotics as surgical prophylaxis, 103 (32%) received antibiotics as empirical therapy, 90 (29%) received antibiotics for documented infections, and 79 (24.8%) received inappropriate antibiotics. Patient characteristics and the incidence and patterns of and the reasons for IAU among different units are summarized in Tables 1 and 2. In 49 (62%) of the 79 instances of IAU, the antibiotics were prescribed by interns or residents. There were no differences between the first and the second survey with respect to patients’ demographic characteristics, patterns of antibiotic prescription, factors associated with IAU, duration of follow‐up, and the length of hospital stay.
By univariate analysis, admission to a surgery department was associated with IAU (32% vs 22%; odds ratio [OR], 1.73; 95% confidence interval [CI], 1.2‐2.9). Infectious diseases consultation was associated with a lower incidence of IAU (5% vs 28%; OR, 0.13; 95% CI, 0.03‐0.58). There were no differences in other characteristics or risk factors among patients who received appropriate antibiotics, compared with those who received inappropriate antibiotics (Table 1). By multivariate analysis, admission to a surgery department (adjusted OR, 2.0; 95% CI, 1.1‐3.6;
) and admission to an obstetric and gynecology department (adjusted OR, 2.0; 95% CI, 1.1‐4.1;
) were associated with IAU, whereas infectious diseases consultations were associated with lower incidences of IAU (adjusted OR, 0.15; 95% CI, 0.03‐0.65;
). Infectious diseases consultation helped in the selection of appropriate antibiotics for empirical treatment (13 [34%] of 38 cases) and for the treatment of documented infections (10 [26%] of 38 cases), prevented the unnecessary use of broad‐spectrum antibiotics (8 [21%] of 38 cases), and streamlined antibiotic use (7 [18%] of 38 cases).
Discussion
Undomthavornsak and colleagues first reported the incidence of IAU to be 52.3% in a tertiary care university hospital in northeastern Thailand.8 The incidence of IAU was 42.3% among patients who received empirical therapy (mainly as a result of the lack of an indication for antibiotic use), 82.4% among patients who received surgical prophylaxis (mainly as a result of delayed use and excessive duration [>72 hours]), and 39.6% among patients who had documented infection (mainly as a result of inappropriate antibiotic choice and redundant antibiotic spectrum). Aswapokee et al.9 reported a 91% incidence of IAU among medical units in a tertiary care university hospital in Bangkok, mainly as a result of the use of antibiotics without any evidence of infection. Thamlikitkul et al.10 later reported the incidence of IAU to be 50% among inpatients and outpatients at the same hospital. Inappropriate antibiotic choices, the duration of surgical prophylaxis, and the use of antibiotics prescribed for acute diarrhea and for upper respiratory tract infections were the main reasons for IAU.10 The findings of our study complement the findings of other studies and suggest that IAU occurs quite commonly in Thailand. The variation in the incidence of IAU may be the result of different study designs, patient demographic characteristics, and definitions of IAU among published studies. The fact that third‐generation cephalosporins are the most common antibiotics associated with IAU may be partially responsible for the trend of increasingly resistant gram‐negative microorganisms in our hospital.4‐5 Data on the incidence and pattern of IAU in tertiary care centers in Thailand are summarized in Table 3.
Although the cross‐sectional nature and the small sample size of our study limit our capacity to identify the incidence of and other relevant factors associated with IAU, our data are the first, to our knowledge, to suggest the benefit of infectious diseases consultation in guiding appropriate antibiotic use in a developing country, as has been consistently shown in developed countries.11‐15 Given the findings of our study, attempts to rectify IAU should be focused on educational interventions aimed at improving the clinical recognition of specific infectious diseases and at establishing antibiotic management programs with the involvement of infectious diseases specialists. Further studies of the factors associated with IAU and interventions to reduce the incidence of IAU in developing countries are needed to help identify effective strategies to control IAU and to prevent the emergence of drug‐resistant microorganisms.
Acknowledgment
This study is supported by the Thai Research Fund (support to A.A.).
References
- 1. Belongia EA, Schwartz B. Strategies for promoting judicious use of antibiotics by doctors and patients. BMJ 1998; 317:668‐671.
- 2. Thamlikitkul V. Antibiotic dispensing by drug store personnel in Bangkok, Thailand. J Antimicrob Chemother 1988; 21:125‐131.
- 3. Srifuengfung S, Polwichai P, Champreeda P, et al. Prevalence of antimicrobial resistance in Streptococcus pneumoniae isolated in Thailand [abstract FP‐A‐5]. In: Program and abstracts of the 9th Western Pacific Congress on Chemotherapy and Infectious Diseases (Bangkok, Thailand). Kuala Lumpur, Malaysia: Western Pacific Society of Chemotherapy; 2004:187.
- 4. Dejsirilert S, Apisarnthanarak A, Kitphati R, et al. The status of antimicrobial resistance in Thailand among gram‐negative pathogens in bloodstream infections: NARST data, 2000‐2003 [abstract FP‐A‐3]. In: Program and abstracts of the 9th Western Pacific Congress on Chemotherapy and Infectious Diseases (Bangkok, Thailand). Kuala Lumpur, Malaysia: Western Pacific Society of Chemotherapy; 2004:185.
- 5. Apisarnthanarak A, Mundy LM. Prevalence, treatment, and outcome of infection due to extended‐spectrum β‐lactamase–producing microorganisms. Infect Control Hosp Epidemiol 2006; 27:326‐327.
- 6. Kunin CM, Tupasi T, Craig WA. Use of antibiotics: a brief exposition of the problem and some tentative solutions. Ann Intern Med 1973; 79:555‐560.
- 7. Bratzler DW, Houch PM. Antimicrobial prophylaxis for surgery: an advisory statement for the national surgical infection prevention project. Clin Infect Dis 2004; 38:1706‐1715.
- 8. Udomthavornsuk B, Tatsanavivat P, Patjanasoontorn B, et al. Antibiotic use at a university hospital. Antiobiotic Working Group of Srinagarind Hospital. J Med Assoc Thai 1990; 72:168‐174.
- 9. Aswapokee N, Vaithayapichet S, Heller RF. Patterns of antibiotic use in medical wards of a university hospital, Bangkok, Thailand. Rev Infect Dis 1990; 12:136‐141.
- 10. Thamlikitkul V, Danchaivijitr S, Kongpattanakul S, Ckokloikaew. Impact of an educational program on antibiotic use in a tertiary care hospital in developing country. J Clin Epidemiol 1998; 51:773‐778.
- 11. Classen DC, Burk JP, Wenzel RP. Infectious diseases consultation: impact on outcomes for hospitalized patients and results of a preliminary study. Clin Infect Dis 1997; 24:468‐470.
- 12. Byl B, Clevenbergh P, Jacobs F, et al. Impact of infectious diseases specialists and microbiology data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 1999; 29:60‐66.
- 13. Tice AD. Editorial response: impact of infectious diseases specialists. Clin Infect Dis 1999; 29:67‐68.
- 14. Johnson JR. Impact of infectious diseases specialists. Clin Infect Dis 2000; 30:838‐839.
- 15. Petrak RM, Sexton DJ, Butera ML, et al. The value of an infectious diseases specialist. Clin Infect Dis 2003; 36:1013‐1017.


